Exhibiting a high prevalence for Rheumatoid Arthritis Market, North America is forecast to

lead the global rheumatoid arthritis therapeutics market in a recent report. In a report, titled
“RHEUMATOID ARTHRITIS THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND
FORECAST, 2018-2025”, Fortune Business Insights identifies numerous factors enabling
growth in the market. According to the report, the global rheumatoid arthritis therapeutics
market is anticipated to exhibit 4.6% CAGR and reach valuation of US$ 33,958.4 Mn in 2025
from US$ 23,822.5 Mn in 2017.

North America to Lead Global Market with Rising Prevalence of Rheumatoid Arthritis

The North America market was worth US$ 9,929.6 Mn in 2017. It is expected to show steady
rise owing to the rising prevalence of rheumatoid arthritis and increasing awareness about
this disorder. Adding to that, governments of North America are investing huge sums for
improving the healthcare and medical facilities in the region. This is helping the rheumatoid
arthritis therapeutics market to grow at an impressive pace in North America.

On the other side, the demand for rheumatoid arthritis treatment is likely to grow at a
considerable pace in Asia Pacific. This is owing to the entry of new drugs, especially biologics,
for the treatment of rheumatoid arthritis in the market. This, coupled with expansion of
healthcare and medical infrastructure in emerging nations, is likely to help rheumatoid
arthritis therapeutic market in Asia Pacific gain more momentum.

Biologics Segment to Account for Highest Market Share

In terms of product type, the biologics segment is anticipated to hold the highest share in the
market in terms of revenue during the forecast period. In 2017, the biologics segment held
87.6% of the rheumatoid arthritis therapeutics market. This is because biologics targeting
specific components of the immune response system help to slow down the rate of
progression of arthritis in the patient. They also help in improving the physical functionality
of patients and are cost efficient as compared to other treatment methods, which helps to
increase the demand for biologics in the market.

Presence of expensive drugs for rheumatoid arthritis treatment, coupled with, favorable
reimbursement policies are factors propelling the global market. Developing countries are
making efforts to improve their medical infrastructure in order to provide medical aid for
diseases such as chronic arthritis and other chronic diseases and this is another key factor
helping the market to grow.

Increasing Number of Medical Professionals Facilitating Rheumatoid Arthritis Treatment

Rise in geriatric population is a key factor enabling growth in the market. The prevalence of
arthritis is considerably high among aged population, which is why a rise in their number is
expected to bode well for the overall market. In case of rheumatoid arthritis, improvement in
diagnostic procedures is favoring growth of the global market for rheumatoid arthritis.
Furthermore, the market is expected to gain from the spread of various awareness programs
and increasing number of skilled healthcare professionals.
In 2017, AbbVie Inc., emerged dominant in the global rheumatoid arthritis therapeutics
market. At present there are numerous market players operating in the market, out of which
about ten players hold 80% of the market. In order to gain competitive advantage, some of
the leading companies are focusing on investing increasingly towards research and
development of novel therapeutics. Some of the other key players operating in the global
rheumatoid arthritis therapeutics market are Gilead Sciences, Inc., F. Hoffmann-La Roche AG,
Eli Lilly and Company, UCB S.A., Bristol-Myers Squibb Company, Amgen Inc., Pfizer Inc.,
Celgene Corporation, and Johnson & Johnson Services, Inc.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping
organizations of all sizes make timely decisions. We tailor innovative solutions for our clients,
assisting them address challenges distinct to their businesses. Our goal is to empower our
clients with holistic market intelligence, giving a granular overview of the market they are
operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help
companies achieve sustainable growth. Our team of experienced analysts and consultants use
industry-leading research tools and techniques to compile comprehensive market studies,
interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities
for our clients. We therefore offer recommendations, making it easier for them to navigate
through technological and market-related changes. Our consulting services are designed to
help organizations identify hidden opportunities and understand prevailing competitive
challenges.

Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com